SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-026299
Filing Date
2018-11-01
Accepted
2018-11-01 17:24:00
Documents
48
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cnat-10q_20180930.htm 10-Q 891128
2 EX-31.1 cnat-ex311_7.htm EX-31.1 10758
3 EX-31.2 cnat-ex312_9.htm EX-31.2 10804
4 EX-32.1 cnat-ex321_11.htm EX-32.1 6845
5 EX-32.2 cnat-ex322_8.htm EX-32.2 6929
  Complete submission text file 0001564590-18-026299.txt   3704515

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cnat-20180930.xml EX-101.INS 721576
7 XBRL TAXONOMY EXTENSION SCHEMA cnat-20180930.xsd EX-101.SCH 31531
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnat-20180930_cal.xml EX-101.CAL 36736
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnat-20180930_def.xml EX-101.DEF 99038
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnat-20180930_lab.xml EX-101.LAB 273671
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnat-20180930_pre.xml EX-101.PRE 199789
Mailing Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127 (858) 376-2600
Conatus Pharmaceuticals Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36003 | Film No.: 181154859
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1